BNP is increased in congestive heart failure, left ventricular hypertrophy, acute myocardial infarction, coronary angioplasty, and hypertension. Elevations are also observed in pulmonary hypertension (indicating right ventricular dysfunction), acute lung injury, hypervolemic states, chronic renal failure and cirrhosis. Decreasing levels indicate therapeutic response to anti-hypertensive therapy. BNP levels may also predict the risk of a cardiovascular event such as a heart attack or stroke.
Alternative Name(s): BNP, Brain Natriuretic Peptide
A significant deviation from the normal range may require further evaluation by your physician.
B-Type Natriuretic Peptide (BNP)
No fasting required.
Estimated turnaround for results is 3 business days. If confirmation testing is required, the estimated time may be extended.
BNP is increased in congestive heart failure, left ventricular hypertrophy, acute myocardial infarction, coronary angioplasty, and hypertension. Elevations are also observed in pulmonary hypertension (indicating right ventricular dysfunction), acute lung injury, hypervolemic states, chronic renal failure and cirrhosis. Decreasing levels indicate therapeutic response to anti-hypertensive therapy. BNP levels may also predict the risk of a cardiovascular event such as a heart attack or stroke.
A significant deviation from the normal range may require further evaluation by your physician.
B-Type Natriuretic Peptide
This test is also known as:
Brain Natriuretic Peptide
BNP
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H or coenzyme R). It is recommended to stop biotin consumption at least 72 hours prior to the collection of specimen. Estimated turnaround for results is 3 business days. If confirmation testing is required, the estimated time may be extended.